Successfully Concludes Strategic Review with Agreement to Sell Small Cells and Fiber Solutions for $8.5 Billion Results in Crown Castle as the Only Pure-Play, Publicly-Traded US Tower Company Increases Capital Efficiency with Updated Capital Allocation Framework, Including Anticipated New Dividend